[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 14, Number 3 (Summer 2017) ::
Sci J Iran Blood Transfus Organ 2017, 14(3): 195-203 Back to browse issues page
Results of the two types of treatment "Rituxmab and Splenectomy" in children with chronic ITP, Mofid Children's Hospital
Dr. B.Sh. Shamsian, Dr. N. Zavar , Dr. F. Ahmadi Khatiri, Dr. M.T. Arzanian, Dr. A.R. Shamshiri, Dr. M. Kazemian
Abstract:   (256 Views)

Abstract
Background and Objectives
In this study, the treatment results of "Rituximab therapy and Splenectomy" in chronic patients of ITP were collected in Mofid Children's Hospital during the years of 1380-1391.
 
Materials and Methods
In this descriptive study, the charts of patients with chronic ITP in years of 1380-1391 were studied. Variables including sex, age at rituximab therapy spelenectomy, treatment response, side effects, prespelenectomy vaccination and prophylactic antibiotics were assessed. The data were analyzed by EXCEL & SPSS 11.5.
 
Results
Chronic ITP patients were 39 cases, 18 males and 21 females; 17 (43.5%) patients received rituximab with 375 mg/mm2 and 100 mg/mm2, between 1-9 times. Three patients  of the first group completely responded (plt > 100000/mm3). Complications, fever and pancytopenia  were seen in 2 patients. The first patient with fever responded to the supportive  treatment. The other patient showed severe pancytopenia after receiving the second dose of Rituximab but at last recovered after 7 months with the supportive therapy.  Six out of 39 (15%) patients of chronic ITP  with the history of variable treatments had been splenectomised and 4(66%) patients had completely responded. Five out of 6 (85%) patients  received  complete  vaccination before splenectomy. No sepsis or thrombosis was seen.
 
Conclusions 
Probably the low number of spelenectomised patients is the result of oral treatment success in prevention of spelenectomising and splenectomy could be replaced by rituximab therapy if accessible. On the other hand, because of the low number of cases, it was statistically impossible to compare the results of the two groups.
 
 

Keywords: Key words: Immune Thrombocytopenic Purpura, Rituximab, Splenectomy
Full-Text [PDF 353 kb]   (82 Downloads)    
Type of Study: Historical Rreview | Subject: Hematology
Send email to the article author

Add your comments about this article
Your username or email:

Write the security code in the box >



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shamsian B, Zavar N, Ahmadi Khatiri F, Arzanian M, Shamshiri A, Kazemian M. Results of the two types of treatment "Rituxmab and Splenectomy" in children with chronic ITP, Mofid Children's Hospital . Sci J Iran Blood Transfus Organ. 2017; 14 (3) :195-203
URL: http://bloodjournal.ir/article-1-1047-en.html
Volume 14, Number 3 (Summer 2017) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.058 seconds with 801 queries by yektaweb 3505